OXALACT
"OXALACT" is a word mark owned by Alnylam Pharmaceuticals, Inc., filed at the EUIPO on July 4, 2024. It is registered and covers classes 42 and 44.
- Status
- Registered
- Since November 28, 2024
- Filed
- July 4, 2024
- Registered
- November 27, 2024
- Expires
- July 4, 2034
- Application no.
- 019049940
- Registration no.
- 019049940
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 2 classes
Who owns OXALACT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Alnylam Pharmaceuticals, Inc.
ALNY
Representative
Areopage
What the mark covers
The products and services OXALACT is filed for, grouped by Nice class.
Biochemical testing for scientific research purposes
Medical testing for diagnostic or treatment purposes; biochemical testing for diagnostic or treatment purposes
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2024/229 Section B.1
- Bulletin 2024/158 Section A.1
About OXALACT
Who owns the trademark "OXALACT"?
The EUIPO trademark "OXALACT" (application 019049940) is owned by Alnylam Pharmaceuticals, Inc.
What is the status of "OXALACT"?
Its status at the EUIPO is: registered.
When was "OXALACT" registered?
It was registered on November 27, 2024 and is due to expire on July 4, 2034.
Get this data via the API
Everything on this page comes from the Signa API. Pull OXALACT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d460a-fda1-70f0-b4a6-1483e6d27b93
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d460a-fda1-70f0-b4a6-1483e6d27b93",
"object": "trademark",
"mark_text": "OXALACT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "019049940",
"filing_date": "2024-07-04",
"nice_classes": [
42,
44
],
"owners": [
{
"name": "Alnylam Pharmaceuticals, Inc.",
"entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
}
]
}